相关实验视频
Updated: Jul 8, 2025

09:33
Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
14.6K
抗癌药物诱导的核子应激的不同状态
Tamara A Potapova1, Jay R Unruh1, Juliana Conkright-Fincham1
1Stowers Institute for Medical Research, Kansas City, United States.
eLife
|December 15, 2023
概括
抗癌药物可以诱导核应激,细胞反应影响核糖体的产生. 这项研究确定了多种药物类别,这些药物类别会触发不同的核应激状态,为癌症治疗开发提供了新的途径.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 核糖体生物生成对细胞生长和能量产生至关重要,特别是在快速增殖的癌细胞中.
- 细胞核是核糖体生物发生的首要部位,也是细胞应激反应的目标.
研究的目的:
- 选现有的抗癌药物,以检查它们诱导核应激的能力.
- 开发一种新型的指标,即"核正常性得分",用于量化核应力.
- 描述各种药物类引起的独特的核应激状态.
主要方法:
- 对抗癌症化合物库的查,以确定诱导核应激的药物.
- 基于蛋白质定位的"核正常度得分"的开发和应用.
- 核细胞应激反应的形态和分子特征.
- 对转录环林依赖激酶 (CDK) 抑制的深入分析,特别是CDK9.
主要成果:
- 发现多种药物类别,包括DNA间隔剂,mTOR/PI3K抑制剂,热冲击蛋白调节剂,蛋白酶体抑制剂和循环素依赖激酶 (CDK) 抑制剂,可诱导核应激.
- 每种药物类别都在核中诱导了独特的形态和分子变化,影响了其生物物理性质.
- 转录CDKs的抑制,特别是CDK9,导致核应激,并确定了核CDK基质,如Treacle,参与RNA聚合酶I招募.
- 由转录CDKs对RNA聚合酶I和II的协调调节被揭示出来.
结论:
- 现有的抗癌药物可以诱导各种形式的核应激,突出核作为一个可行的治疗点.
- 这些发现表明,在开发新型抗癌疗法时,应考虑核子应激诱导.
- 转录性CDKs通过对RNA聚合酶I和II的调节,在协调核糖体生物发生过程中发挥关键作用.
相关概念视频
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
167
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
167
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K

